Comment Letter
Comments in Response to a CBO Call for New Research on Obesity
November 2, 2023
Featured Experts: Dana Goldman, PhD, Darius Lakdawalla, PhD, Karen Van Nuys, PhD, Alison Sexton Ward, PhD, Bryan Tysinger, PhD, Barry Liden, JD
Research
All Research Featured Research
Perspective
How the Secrecy of Middlemen Inflates Drug Prices
October 14, 2023
Featured Experts: Neeraj Sood, PhD, Karen Van Nuys, PhD
Perspective
Congress Wants a Better Value. So Why Are They Eliminating Performance Based Payment?
October 12, 2023
Featured Experts: Joseph Grogan, JD
Comment Letter
Comments to CMS on Proposed Guidance for Coverage with Evidence Development
August 25, 2023
Featured Experts: Alice Chen, PhD, Joseph Grogan, JD, Mireille Jacobson, PhD, Geoffrey Joyce, PhD, Darius Lakdawalla, PhD, Barry Liden, JD, Eugene Lin, MD, MS, Karen Van Nuys, PhD, William Padula, PhD, Alison Sexton Ward, PhD, Julie Zissimopoulos, PhD
Perspective
Beware of the Government’s Healthcare ‘Truth’ Peddlers
August 22, 2023
Featured Experts: Joseph Grogan, JD
Journal Article
Disadvantaging Rivals: Vertical Integration in the Pharmaceutical Market
August 14, 2023
Featured Experts: Neeraj Sood, PhD
Journal Article
Insulin Fills by Medicare Enrollees and Out-of-Pocket Caps Under the Inflation Reduction Act
July 24, 2023
Featured Experts: Rebecca Myerson, PhD, MPH, Dima M. Qato, PharmD, MPH, PhD, Dana Goldman, PhD
Perspective
Blame Capitalism? Why Hundreds of Decades-Old Yet Vital Drugs Are Nearly Impossible to Find
July 20, 2023
Featured Experts: Geoffrey Joyce, PhD
Journal Article
Cancer Drug Trastuzumab And Its Biosimilars Compete On Price For Market Share
June 6, 2023
Featured Experts: Alice Chen, PhD, Maria-Alice Manetas, Karen Van Nuys, PhD
Perspective
Four Ways to Make Drug Price Negotiations Work for Everyone
May 26, 2023
Featured Experts: Dana Goldman, PhD, Darius Lakdawalla, PhD
Testimony
Testimony on Policies that Inhibit Innovation and Patient Access
May 10, 2023
Featured Experts: Darius Lakdawalla, PhD
Perspective
A Strategy for Value-Based Drug Pricing Under the Inflation Reduction Act
May 4, 2023
Featured Experts: Darius Lakdawalla, PhD, Charles E. Phelps, PhD
Comment Letter
Comments to CMS on the Inflation Reduction Act’s Drug Price Negotiation Program
April 17, 2023
Featured Experts: Dana Goldman, PhD, Charles E. Phelps, PhD, Darius Lakdawalla, PhD, Joseph Grogan, JD, Karen Van Nuys, PhD, Barry Liden, JD, William Padula, PhD
White Paper
Mitigating the Inflation Reduction Act’s Adverse Impacts on the Prescription Drug Market
April 13, 2023
Featured Experts: Dana Goldman, PhD, Joseph Grogan, JD, Darius Lakdawalla, PhD, Barry Liden, JD, Erin Trish, PhD